retatrutide phase 2 results 2024 2025 press release Lilly's triple agonist, retatrutide, successful in two additional 3 obesity trials, delivering significant improvements in weight and A1C Retatrutide (LY3437943): Mechanism of Action

In accordance with TriNetXs data governance policies, only de-identified, summary-level datasets were accessible for analysis

If you do notice changes, there are steps you can take to support your body as it adjusts to weight loss and other changes

Exploring Quality of Life, Stress, and Risk Factors Associated with Irritable Bowel Syndrome for Female University Students in Taiwan

Trimethylamine N-Oxide, the microbiome, and heart and kidney disease

Storage & Stability Lyophilized -20C Stable for 24+ months when stored desiccated and protected from light Reconstituted 2-8C Use within 14 days

Accidentally took expired semaglutide If you accidentally used expired semaglutide , the medication is unlikely to be harmful, but it may have reduced potency